Forbes: New research shines light on how COVID-19 can damage the brain

July 30, 2021

Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in Forbes. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read story


Thinking impaired in 60% of COVID-19 survivors, study finds

July 29, 2021

Loss of smell also observed in Argentine sample. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu DENVER, Colo. (July 29, 2021) — In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San […]

Brain



Healthline: How tooth loss can be connected to cognitive decline, dementia

July 8, 2021

Dr. Megan Sullivan, School of Dentistry, is quoted in this story and discusses the importance of oral health. Sullivan said dentists are trained not to just treat your teeth, but also to assess your overall health and share any concerns they may see from your oral health with you. Read story.


Depression, tau deposits seen in subset of middle-aged persons

June 17, 2021

Framingham Heart Study analysis finds association in APOE ε4 allele carriers. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 17, 2021) — Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new […]

man with clinical depression